Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George R Bailie

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Pharmacotherapy|May 28, 2004
From dialysis outcomes quality initiative to kidney disease outcomes quality initiative: new clinical practice guidelines in nephrology--what the practicing pharmacist needs to knowGeorge R Bailie
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 4, 2012
Comparison of rates of reported adverse events associated with i.v. iron products in the United StatesGeorge R Bailie
Arzneimittel-Forschung|July 23, 2010
Efficacy and safety of ferric carboxymaltose in correcting iron-deficiency anemia: a review of randomized controlled trials across different indicationsGeorge R Bailie
Seminars in Dialysis|October 3, 2002
Comparative review of the pharmacokinetics of vitamin D analoguesGeorge R Bailie, Curtis A Johnson
Clinical Advances in Hematology & Oncology : H&O|March 10, 2012
Differences in the reporting rates of serious allergic adverse events from intravenous iron by country and populationGeorge R Bailie, Jan-Jaap Verhoef
Pharmacotherapy|November 25, 2005
Clinical practice guidelines for bone metabolism and disease in chronic kidney disease: an overviewGeorge R Bailie, Shaul G Massry,
Seminars in Dialysis|November 20, 2002
Treatment of peritonitis in APD: pharmacokinetic principlesHarold J Manley, George R Bailie
Nephron. Clinical Practice|April 13, 2005
Comparison of intravenous iron sucrose to oral iron in the treatment of anemic patients with chronic kidney disease not on dialysisChaim Charytan, Wajeh Qunibi, George R Bailie, et al.
Pharmacotherapy|December 26, 2003
Factors associated with long-term antibody production induced by hepatitis B vaccine in patients undergoing hemodialysis: a retrospective cohort studyRowland J Elwell, Marianne Neumann, George R Bailie
Pharmacotherapy|June 28, 2005
Clinical practice guidelines in nephrology: evaluation, classification, and stratification of chronic kidney diseaseGeorge R Bailie, Katrin Uhlig, Andrew S Levey
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Pharmacotherapy|May 28, 2004
From dialysis outcomes quality initiative to kidney disease outcomes quality initiative: new clinical practice guidelines in nephrology--what the practicing pharmacist needs to knowGeorge R Bailie
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 4, 2012
Comparison of rates of reported adverse events associated with i.v. iron products in the United StatesGeorge R Bailie
Arzneimittel-Forschung|July 23, 2010
Efficacy and safety of ferric carboxymaltose in correcting iron-deficiency anemia: a review of randomized controlled trials across different indicationsGeorge R Bailie
Seminars in Dialysis|October 3, 2002
Comparative review of the pharmacokinetics of vitamin D analoguesGeorge R Bailie, Curtis A Johnson
Clinical Advances in Hematology & Oncology : H&O|March 10, 2012
Differences in the reporting rates of serious allergic adverse events from intravenous iron by country and populationGeorge R Bailie, Jan-Jaap Verhoef
Pharmacotherapy|November 25, 2005
Clinical practice guidelines for bone metabolism and disease in chronic kidney disease: an overviewGeorge R Bailie, Shaul G Massry,
Seminars in Dialysis|November 20, 2002
Treatment of peritonitis in APD: pharmacokinetic principlesHarold J Manley, George R Bailie
Nephron. Clinical Practice|April 13, 2005
Comparison of intravenous iron sucrose to oral iron in the treatment of anemic patients with chronic kidney disease not on dialysisChaim Charytan, Wajeh Qunibi, George R Bailie, et al.
Pharmacotherapy|December 26, 2003
Factors associated with long-term antibody production induced by hepatitis B vaccine in patients undergoing hemodialysis: a retrospective cohort studyRowland J Elwell, Marianne Neumann, George R Bailie
Pharmacotherapy|June 28, 2005
Clinical practice guidelines in nephrology: evaluation, classification, and stratification of chronic kidney diseaseGeorge R Bailie, Katrin Uhlig, Andrew S Levey
Pageof 4